Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6676
Innovator US Equity Power Buffer ETF May
PMAY
$821M
| $19K | ﹤0.01% |
461
| – | – |
2024 Q3
7 quarters
|
|
6677
ENDRA Life Sciences
NDRA
$8.19M
| $18.9K | ﹤0.01% |
3,546
| – | – |
2025 Q4
2 quarters
|
|
6678
Context Therapeutics
CNTX
$27.9M
| $18.9K | ﹤0.01% |
34,121
+25,044
| +276% | +$50.8K |
2026 Q1
1 quarter
|
|
6679
Global X Hydrogen ETF
HYDR
$93.8M
| $18.8K | ﹤0.01% |
354
+269
| +316% | +$15K |
2024 Q3
7 quarters
|
|
6680
FT Vest US Equity Moderate Buffer ETF December
GDEC
$386M
| $18.7K | ﹤0.01% |
471
| – | – |
2024 Q4
6 quarters
|
|
6681
Southland Holdings
SLND
$42.6M
| $18.7K | ﹤0.01% |
28,105
-66,517
| -70% | -$73K |
2023 Q2
12 quarters
|
|
6682
US Global GO Gold and Precious Metal Miners ETF
GOAU
$193M
| $18.6K | ﹤0.01% |
501
-10
| -2% | -$427 |
2020 Q4
22 quarters
|
|
6683
SEI Select Small Cap ETF
SEIS
$603M
| $18.5K | ﹤0.01% |
552
| – | – |
2025 Q3
3 quarters
|
|
6684
Franklin International Aggregate Bond ETF
FLIA
$425M
| $18.5K | ﹤0.01% |
901
+899
| +44,950% | +$18.3K |
2024 Q1
9 quarters
|
|
6685
Natixis Gateway Quality Income ETF
GQI
$300M
| $18.5K | ﹤0.01% |
312
-421
| -57% | -$24.4K |
2026 Q1
1 quarter
|
|
6686
Ellomay Capital Ltd
ELLO
$300M
| $18.4K | ﹤0.01% |
1,000
-200
| -17% | -$4.64K |
2024 Q4
6 quarters
|
|
6687
Fidelity Electric Vehicles and Future Transportation ETF
FDRV
$24.2M
| $18.3K | ﹤0.01% |
943
| – | – |
2023 Q2
12 quarters
|
|
6688
First Trust Active Factor Large Cap Growth ETF
AFGR
$93.4M
| $18.2K | ﹤0.01% |
498
| – | – |
2024 Q2
8 quarters
|
|
6689
Themes Generative Artificial Intelligence ETF
WISE
$27.8M
| $18.1K | ﹤0.01% |
468
-100
| -18% | -$3.86K |
2024 Q3
7 quarters
|
|
6690
Invesco NASDAQ Biotechnology ETF
IBBQ
$106M
| $18K | ﹤0.01% |
551
| – | – |
2026 Q1
1 quarter
|
|
6691
Xcel Brands
XELB
$3.94M
| $18K | ﹤0.01% |
10,000
| – | – |
2024 Q1
9 quarters
|
|
6692
Thornburg Multi Sector Bond ETF
TMB
$262M
| $18K | ﹤0.01% |
709
+247
| +53% | +$6.29K |
2025 Q3
3 quarters
|
|
6693
First Trust India Nifty 50 Equal Weight ETF
NFTY
$97.8M
| $17.9K | ﹤0.01% |
333
-3
| -0.9% | -$160 |
2018 Q2
32 quarters
|
|
6694
Empire Petroleum
EP
$131M
| $17.8K | ﹤0.01% |
6,633
-6,369
| -49% | -$17.7K |
2022 Q2
16 quarters
|
|
6695
Capital Group Conservative Equity ETF
CGCV
$2.08B
| $17.7K | ﹤0.01% |
540
+327
| +154% | +$10.3K |
2025 Q2
4 quarters
|
|
6696
ProShares Trust Short MSCI Emerging Markets
EUM
$13.6M
| $17.7K | ﹤0.01% |
1,140
-579,071
| -100% | -$9.64M |
2025 Q4
2 quarters
|
|
6697
Cohen & Steers Natural Resources Active ETF
CSNR
$121M
| $17.6K | ﹤0.01% |
528
+478
| +956% | +$17.5K |
2025 Q4
2 quarters
|
|
6698
Quantum Cyber N.V.
QUCY
$113M
| $17.6K | ﹤0.01% |
11,187
+10,998
| +5,819% | +$15.8K |
2023 Q2
12 quarters
|
|
6699
Brandes US Value ETF
BUSA
$312M
| $17.4K | ﹤0.01% |
442
-1,146
| -72% | -$44.5K |
2024 Q3
7 quarters
|
|
6700
K-Tech Solutions
KMRK
$24.9M
| $17.4K | ﹤0.01% |
+20,000
| New | +$43.3K |
2026 Q2
0 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.